Zhang Jinguo について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Han Xinghua について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Lin Lin について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Chen Jian について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Wang Feng について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Ding Qi について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Wang Lingyu について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Wei Jie について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Wang Yong について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Pan Yueyin について
Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China について
Oxidative Medicine and Cellular Longevity (Web) について
アルゴリズム について
浸潤 について
遺伝 について
遺伝子 について
免疫療法 について
不均一性 について
主成分分析 について
ターゲティング について
腫瘍免疫 について
細胞浸潤 について
肺腺癌 について
癌免疫療法 について
微小環境 について
免疫細胞 について
臨床的特徴 について
生体防御と免疫系一般 について
遺伝子発現 について
免疫 について
チェックポイント について
発現パターン について
肺腺癌 について
サブタイプ について
治療 について
指標 について
同定 について